Antibiotic Treatment for UTI in Males

Introduction to Treatment Guidelines

• The European Urology guidelines recommend that all UTIs in males are considered complicated by definition and require 7-14 days of treatment, with mandatory urine culture and susceptibility testing before initiating empiric therapy 1, 2

Critical First Step: Obtain Urine Culture

• Urine culture with susceptibility testing is mandatory before starting antibiotics to guide targeted therapy, as male UTIs have a broader microbial spectrum and higher antimicrobial resistance rates than uncomplicated UTIs in women 1, 2
• Common pathogens include E. coli, Proteus spp., Klebsiella spp., Pseudomonas spp., Serratia spp., and Enterococcus spp. 1

First-Line Empiric Oral Antibiotics

• For empiric treatment while awaiting culture results, fluoroquinolones are preferred if local resistance is <10%: Ciprofloxacin 500-750 mg twice daily for 7 days, or Levofloxacin 750 mg once daily for 5-7 days 1, 2

Alternative Oral Options

• Alternative oral options when fluoroquinolones cannot be used include Trimethoprim-sulfamethoxazole 160/800 mg twice daily for 7-14 days, avoiding if local resistance >20% 1

Treatment Duration Specifics

• Standard duration: 7 days minimum for uncomplicated male UTI, with extended duration of 14 days when prostatitis cannot be excluded, which is common in males with UTI symptoms 1, 2

Parenteral Options for Severe Presentations

• If the patient appears systemically ill or has pyelonephritis, initiate IV therapy with Ciprofloxacin 400 mg IV twice daily, Levofloxacin 750 mg IV once daily, Ceftriaxone 1-2 g IV once daily, Cefepime 1-2 g IV twice daily, or Piperacillin-tazobactam 2.5-4.5 g IV three times daily 1

Step-Down to Oral Therapy

• Transition to oral antibiotics when clinically stable and afebrile for 48 hours, and adjust antibiotic selection based on culture and susceptibility results 1, 2

Critical Pitfalls to Avoid

• Never use amoxicillin or ampicillin empirically due to very high worldwide resistance rates and poor efficacy, and consider prostatitis in all males with UTI symptoms, as this requires 14 days of treatment and fluoroquinolones have better prostatic penetration 1, 2

Special Considerations for Multidrug-Resistant Organisms

• If patient has risk factors for resistant organisms, consider broader-spectrum parenteral agents: ceftolozane-tazobactam 1.5 g IV three times daily, ceftazidime-avibactam 2.5 g IV three times daily, or meropenem 1 g IV three times daily, and Aminoglycosides (gentamicin 5 mg/kg IV once daily or amikacin 15 mg/kg IV once daily) are effective alternatives, especially with prior fluoroquinolone resistance 1, 4